This inventor holds 1 USPTO granted patent. Top assignee: In-Silico Sciences, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Yoshiaki Watanabe: Innovator in Ligand Screening Technology
Introduction
Yoshiaki Watanabe is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of ligand screening technology. His innovative work focuses on improving the accuracy of receptor-ligand binding predictions.
Latest Patents
Watanabe holds a patent for a "Ligand searching device, ligand searching method, program, and recording medium." This invention is designed to enhance ligand screening apparatuses and methods for studying the binding analysis between receptors and ligands. The patent outlines a process that includes the analysis and calculation of normal modes, followed by the calculation of dihedral angle fluctuations in a steady state. By conducting molecular dynamic calculations while imposing constraints on each atom, Watanabe's invention predicts the dynamic structure of receptors with greater accuracy. This advancement is particularly beneficial for studying induced-fit type receptors.
Career Highlights
Watanabe is associated with In-Silico Sciences, Inc., where he continues to develop innovative technologies in the field of molecular dynamics and ligand screening. His work has garnered attention for its potential applications in drug discovery and biochemistry.
Collaborations
Watanabe collaborates with notable colleagues, including Ryoichi Arai and Hideaki Umeyama. Their combined expertise contributes to the advancement of research in ligand screening and molecular dynamics.
Conclusion
Yoshiaki Watanabe's contributions to ligand screening technology exemplify the impact of innovative thinking in scientific research. His patent and ongoing work at In-Silico Sciences, Inc. highlight the importance of accurate receptor-ligand binding predictions in advancing drug discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile